GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSD11B1, HSPA1A, INSR, KDR, MAOB, MET, PPARA, SLC1A1, SMAD3, SRC, TEK, XDH |
11.2476 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
11.0569 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
11.0569 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
9.94382 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
9.86359 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
8.98755 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, PDE5A, PTPN1, SRC, TEK, XDH |
8.92045 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, XDH |
8.68061 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTPN1, SRC, TEK, XDH |
8.62502 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, GRIK5, GRM5, HMGCR, IGF1R, INSR, MAOB, MMP2, MMP9, PPARA, RORC, SRC, TEK |
8.5691 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MMP2, PPARA, RORC, SMAD3, SRC, TEK |
8.5691 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
8.35479 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
8.33839 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, EGFR, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PDE5A, PIM1, SMAD3, SRC, TEK, XDH |
8.19671 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
8.1402 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, GPR35, GRIK5, GRM5, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
8.13223 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, GRM1, GRM3, GRM5, GRM8 |
7.65355 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GRIK5, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.49767 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GRIK5, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH |
7.41103 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.41103 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MMP2, MMP9, PPARA, RORC, SMAD3, SRC, TEK |
7.41103 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
7.33579 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.09521 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.0605 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
6.97477 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FDPS, FUT7, HMGCR, HSD11B1, MET, PPARA |
6.9514 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PIM1, PTPN1, SRC, TEK, XDH |
6.85956 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
6.85851 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GRIK5, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH |
6.85851 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, DRD1, DRD2, EGFR, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
6.84852 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, DRD1, DRD2, EGFR, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
6.84852 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, DRD1, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MAOB, MMP2, PPARA, SMAD3, SRC, TEK |
6.83225 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.83225 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD1, DRD2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.83225 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MAOB, MMP9, SRC |
6.82597 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
6.82597 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP4, GRM1, GRM5, GRM8, HMGCR, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
6.82193 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, EGFR, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
6.73192 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.67777 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.6627 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PIM1, PTPN1, SRC, TEK, XDH |
6.55552 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.50143 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.40427 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, RORC, SMAD3, SRC |
6.28913 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, MMP9, PDE5A, PPARA, PTPN1, SRC, TEK, XDH |
6.19563 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC |
6.19563 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
6.12363 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
6.11828 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.11828 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, MMP9, PDE5A, PTPN1, SRC, TEK, XDH |
6.11828 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.94593 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.81335 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PTPN1, SRC, TEK, XDH |
5.70006 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.64868 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.64868 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, HMGCR, KDR, MAOB, SRC |
5.59762 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FDPS, HMGCR |
5.56663 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS, HMGCR, HSD11B1 |
5.56327 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
5.56226 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PDE5A, PTPN1, SRC, TEK, XDH |
5.55435 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, MMP2, RORC, SMAD3, SRC |
5.52648 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, FDPS, HMGCR, MAOB |
5.50235 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, DRD2, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, KDR, PDE5A, PTPN1, SRC, TEK, XDH |
5.50235 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.50235 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, DRD2, EGFR, FLT3, GRM1, HMGCR, INSR, KDR, PDE5A, PTPN1, SRC, TEK, XDH |
5.48571 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, EGFR, GRIK5, INSR, MAOB, SLC1A1, SMAD3 |
5.48571 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, EGFR, FABP3, FABP4, FDPS, FUT7, HMGCR, MET, PPARA |
5.48158 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, FLT3, MAOB, RORC, SRC, TEK |
5.4748 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.4748 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.44926 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PDE5A, PTPN1, SRC, TEK |
5.44168 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, EGFR, GPR35, GRIK5, GRM5, HCAR2, HMGCR, HSPA1A, INSR, MAOB, MMP9, PPARA, PTPN1, SMAD3, SRC |
5.4313 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, PDE5A, PTPN1, SRC |
5.41114 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
5.39507 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1 |
5.37177 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PDE5A, PTPN1, SRC, TEK, XDH |
5.3634 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FDPS, FUT7, HMGCR, HSPA1A, PDE5A, PIM1, PPARA, XDH |
5.3634 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, EGFR, GRM1, HMGCR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK |
5.28546 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, F3, FLT3, HMGCR, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, TEK |
5.23136 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PDE5A, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.22672 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PDE5A, PTPN1, SRC, TEK |
5.22308 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTPN1, RORC, SMAD3, SRC |
5.2129 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, MAOB, PPARA, SRC, TEK |
5.1823 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FDPS, FLT3, HCAR2, HMGCR, PPARA, RORC, SRC, TEK |
5.17719 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
5.11582 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, PDE5A, PTPN1, SRC |
5.08235 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
5.07419 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
5.03003 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, EGFR, HCAR2, HMGCR, KDR, SRC |
4.98639 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.94177 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.89794 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, F10, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
4.89794 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FDPS |
4.8766 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, DRD2, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
4.83349 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.77996 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, HCAR2, HMGCR, HSD11B1 |
4.69027 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.68448 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.63659 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.60098 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.59018 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, DRD1, DRD2, EGFR, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.58451 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.58402 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, HSPA1A, MAOB |
4.54332 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MAOB, MET, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.53666 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, F3, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, PDE5A, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.4849 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DRD2, DUSP3, EGFR, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.4849 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
4.4849 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
4.47947 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DRD2, DUSP3, FABP4, GPR35, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.47324 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, GRM1, GRM3, GRM5, GRM8 |
4.47324 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, PDE5A, PTPN1, SRC, TEK |
4.4063 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
4.38755 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD11B1, INSR, KDR, PPARA, SMAD3, SRC, TEK |
4.38755 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.32787 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MAOB, MMP1, MMP2, MMP9, PDE5A, SRC, XDH |
4.3255 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.31506 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, BCL2, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, MMP9, PDE5A, PTPN1, SRC, TEK, XDH |
4.28722 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, PDE5A, PTPN1, SRC, TEK |
4.24125 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CYP1B1, DRD2, EGFR, F3, HCAR2, HMGCR, HSPA1A, KDR, MET, MMP9, PDE5A, PIM1, SLC1A1, SMAD3, SRC, TEK |
4.2099 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FDPS, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, XDH |
4.18599 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC |
4.16205 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSD11B1, INSR, KDR, MAOB, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
4.15883 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.13568 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
4.11185 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP3, FABP4, GPR35, GRM3, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MAOB, MET, MMP9, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.07483 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AURKB, BCL2, CDC25B, DRD2, EGFR, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, MMP9, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
4.0452 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, AURKB, BCL2, CDC25B, DRD2, EGFR, F3, FLT3, GRM1, GRM5, HSPA1A, INSR, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
4.03481 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EGFR, F3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PDE5A, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.03481 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, MAOB, RORC, SRC |
4.02737 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, FUT7, HMGCR, HSD11B1, INSR, KDR, MAOB, MET, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
4.02631 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DUSP3, EGFR, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.96741 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD1, DRD2, DUSP3, EGFR, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.95136 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, DRD1, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.94925 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, HMGCR, IGF1R, INSR, PDE5A, PTPN1, SRC |
3.94925 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, EGFR, FABP3, HMGCR, KDR, MAOB, SRC |
3.94321 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
3.9155 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.89236 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PDE5A, PTPN1, SMAD3, SRC, TEK, XDH |
3.88664 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.88613 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, GRM1, GRM5, INSR, PDE5A, PTPN1, SRC |
3.87389 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
3.87389 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DUSP3, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
3.85597 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, RORC, SRC |
3.84914 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MAOB, MMP9 |
3.83863 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.83338 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, MAOB |
3.82847 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
3.81488 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, SLC1A1 |
3.81488 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CYP19A1, DRD1, DRD2, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
3.81201 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FDPS, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.79199 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FDPS, FLT3, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.75697 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.69961 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, EGFR, F3, FABP4, HMGCR, KDR, MET, PPARA, SMAD3, TEK |
3.68766 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.64993 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.63018 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, FABP3, GPR35, GRM1, GRM5, SMAD3 |
3.62486 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.60298 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.58085 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, MAOB |
3.53385 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AXL, BCL2, CA2, CYP1B1, DRD2, EGFR, F3, GPR35, GRM1, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PDE5A, PIM1, SLC1A1, SMAD3, SRC, TEK, XDH |
3.52776 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8 |
3.52255 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, PDE5A, PTPN1, SRC |
3.50198 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1 |
3.4957 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
3.49085 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR, MAOB |
3.48432 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FDPS, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, XDH |
3.47491 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2, EGFR |
3.45444 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.44718 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
DRD2, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK |
3.40213 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.38142 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.38085 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, FDPS, HMGCR, HSD11B1 |
3.36303 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, HMGCR, PPARA, SMAD3, TEK |
3.35473 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.35372 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.35372 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, EGFR, PPARA, RORC, SRC |
3.31227 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.25094 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9 |
3.25094 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.23561 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.23561 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.22879 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, MAOB |
3.20309 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.17 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.17 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, GPR35, MAOB, MMP9 |
3.12383 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, DRD2, EGFR, GPR35, GRM1, HCAR2, PDE5A, SLC1A1, SMAD3 |
3.09202 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, MAOB, SRC |
3.0852 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, EGFR, GPR35, GRM1, GRM5, SMAD3 |
3.07754 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, EGFR, HCAR2 |
2.99998 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, FABP4, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
2.99411 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, MAOB |
2.92603 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, MAOB |
2.92603 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.92603 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, SLC1A1 |
2.92603 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, GRM3, GRM8, INSR, PDE5A, PPARA |
2.91663 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, MAOB, SRC |
2.91594 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, EGFR, HMGCR, SRC, TEK |
2.91594 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, GRM3, GRM8, INSR, PDE5A, PPARA |
2.84279 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, EGFR, HCAR2, INSR, SMAD3, SRC |
2.83862 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.82966 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, XDH |
2.79277 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.78519 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, GRM5, IGF1R, INSR, PPARA, SRC, TEK |
2.7329 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.72805 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.72559 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, PDE5A, PTPN1, SRC |
2.7227 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, EGFR, FLT3, RORC, SRC |
2.7227 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.7227 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.7227 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.7227 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.7227 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK |
2.70846 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCL2, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.70301 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DUSP3, EGFR, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.69305 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.68809 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.67564 |
[BP] GO:0045936 |
None
|
DRD2, DUSP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH |
2.65919 |
[BP] GO:0010563 |
None
|
DRD2, DUSP3, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, PTPN1, XDH |
2.65574 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.64118 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, BCL2, DRD2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.63684 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.63654 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, BCL2, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.63654 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.60636 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
2.60636 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.59518 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.59518 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, SMAD3, SRC, XDH |
2.59495 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
AURKB, CDC25B, CYP1A1, DRD2, DUSP3, EGFR, INSR, SRC |
2.59495 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.59495 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.59495 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, GPR35, GRM5, MAOB, MMP9 |
2.5941 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.5941 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, EGFR, GRM5, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK |
2.58324 |
[BP] GO:0050890 |
None
|
ADORA1, DRD1, DRD2, EGFR, GRM5, HMGCR, INSR |
2.58042 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, SMAD3, SRC, XDH |
2.5711 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.56063 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, MAOB, XDH |
2.54053 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.5305 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.5267 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.50997 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MAOB, PDE5A, XDH |
2.50594 |
[BP] GO:0007267 |
None
|
ADORA1, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.50594 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.49716 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, EGFR, GPR35, GRM1, GRM5, SMAD3 |
2.49716 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, EGFR, GRM1, GRM5, GRM8, HMGCR, INSR, PDE5A, SRC, TEK |
2.49434 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.48199 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.47067 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.47067 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, EGFR, GRM5, IGF1R, INSR, MMP2, SRC |
2.44103 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
DRD2, EGFR, HMGCR, KDR, SRC, TEK |
2.44103 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1 |
2.43803 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.39295 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37505 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
2.3748 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, FLT3, MET, PIM1, SRC, TEK |
2.37062 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.36505 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2 |
2.36403 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, EGFR, HMGCR, SRC, TEK |
2.35865 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.35865 |
[BP] GO:0051094 |
positive regulation of developmental process
|
AXL, BCL2, CA2, CYP1B1, DRD2, F3, HMGCR, INSR, KDR, PDE5A, PIM1, SMAD3, SRC, TEK |
2.35865 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
AURKB, BCL2, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
2.3557 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.3557 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.35496 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AURKB, BCL2, CSNK2A1, DRD2, DUSP3, EGFR, FABP4, GRM3, GRM8, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH |
2.34948 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, GRIK5, HCAR2, HMGCR, MMP9, SMAD3, SRC, XDH |
2.34948 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.34079 |
[BP] GO:0008299 |
None
|
CYP1A1, FDPS, HMGCR |
2.34079 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9 |
2.33598 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CYP1B1, DUSP3, KDR, NUAK1, PDE5A, PPARA, SMAD3, SRC, TEK |
2.3113 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD2, EGFR, GPR35, GRM1, GRM5, SMAD3 |
2.30339 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, DRD2, EGFR, GRM1, GRM5, HMGCR, INSR, PPARA |
2.30324 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.29405 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
2.26792 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.26582 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.26582 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
2.26105 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, DRD2, EGFR, GRM1, INSR, PTPN1, SRC |
2.26105 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, EGFR, GRIK5, HCAR2, HMGCR, MAOB, SRC |
2.25691 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, EGFR, FLT3, GRM5, IGF1R, INSR, MMP2, SMAD3, SRC |
2.25691 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.25691 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.25691 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.25691 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.25691 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, DRD1, EGFR, GRM5, IGF1R, INSR, MMP2, SRC |
2.25186 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
2.25186 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HMGCR, HSD11B1 |
2.24449 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CYP1A1, DRD1, DRD2, EGFR, FABP4, FLT3, FUT7, HMGCR, KDR, MET, MMP2, MMP9, RORC, SMAD3, SRC, TEK |
2.24259 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.24252 |
[BP] GO:0007612 |
None
|
DRD1, DRD2, GRM5, HMGCR, INSR |
2.24252 |
[BP] GO:1900543 |
None
|
DRD2, GRM3, GRM8, PPARA |
2.23822 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MMP1, MMP9, SRC, TEK |
2.22297 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.21808 |
[BP] GO:0045980 |
None
|
DRD2, GRM3, GRM8, PPARA |
2.21808 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, MAOB |
2.20379 |
[BP] GO:0023052 |
None
|
ADORA1, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.19634 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.1893 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.1893 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.1893 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.1893 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.1893 |
[BP] GO:0051482 |
None
|
DRD1, GPR35, GRM1 |
2.18821 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, MAOB |
2.18821 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, GPR35, GRM1, GRM5, SMAD3 |
2.18821 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, PDE5A, SMAD3, XDH |
2.18492 |
[BP] GO:0030799 |
None
|
DRD1, DRD2, GRM3, GRM8, PDE5A |
2.17645 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
2.17606 |
[BP] GO:0051726 |
regulation of cell cycle
|
AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC |
2.16867 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HMGCR, SRC |
2.15245 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.15093 |
[BP] GO:0050730 |
None
|
ADORA1, EGFR, FLT3, GRM5, PTPN1, SRC |
2.14947 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, GPR35, GRM1, GRM5, SMAD3 |
2.11961 |
[BP] GO:1901361 |
None
|
CYP19A1, CYP1A1, CYP1A2, CYP3A4, HSPA1A, MAOB, PDE5A, XDH |
2.11518 |
[BP] GO:0007611 |
None
|
DRD1, DRD2, EGFR, GRM5, HMGCR, INSR |
2.11427 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD2, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
2.11427 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.11427 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.11427 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.11071 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.11071 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MET, MMP1, MMP9, SRC, TEK |
2.11071 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, HSPA1A, MAOB, PDE5A, SRC, XDH |
2.10626 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC |
2.08505 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.08421 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.08421 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2 |
2.08421 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.08421 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, EGFR, GRIK5, HCAR2, HMGCR, MAOB, SRC |
2.06308 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3 |
2.06245 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.0605 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.0605 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.0605 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.0605 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.0605 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.0605 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5 |
2.05758 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.05758 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.0573 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.02005 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.02005 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK |
2.01755 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTPN1, SRC |
2.00708 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, DRD1, DRD2, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, SLC1A1, SRC, TEK |
6.11828 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, DRD1, DRD2, F10, F3, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
5.67785 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA2, CA4, CSNK2A1, DRD1, DRD2, EGFR, F10, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SMAD3, SRC, TEK |
5.48571 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, AXL, CA2, CA4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, SRC, TEK |
5.1008 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, F10, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MAOB, MET, MMP2, PIM1, PTPN1, SLC1A1, SMAD3, SRC, TEK |
4.50513 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DUSP3, EGFR, F10, F3, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MAOB, MET, PTPN1, SLC1A1, SRC, TEK |
4.39221 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, DRD1, DRD2, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
4.09705 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.62486 |
[CC] GO:0014069 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.33788 |
[CC] GO:0099572 |
None
|
ADORA1, DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
3.33788 |
[CC] GO:0043235 |
receptor complex
|
EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
2.95279 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.79237 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.53492 |
[CC] GO:0043197 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.47067 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.45998 |
[CC] GO:0044309 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.44103 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, F10, FLT3, GRIA2, HMGCR, HSD11B1, PTPN1 |
2.27856 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA4, CYP3A4, DRD1, DRD2, EGFR, F10, F3, FLT3, FUT7, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MAOB, MET, SLC1A1, TEK |
2.15515 |
[CC] GO:0098794 |
None
|
ADORA1, DRD2, GRIA2, GRIA4, GRM3 |
2.06664 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.0605 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.33839 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.14142 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
8.14142 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.49767 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PTPN1, SRC, TEK, XDH |
7.49767 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, F10, F3, FABP3, FABP4, FDPS, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, XDH |
7.4626 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
7.41103 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
7.41103 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
7.29422 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, TEK |
7.23965 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, EGFR, F3, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
7.0605 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH |
7.00079 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.89583 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK |
5.9011 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.56327 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.50235 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.28756 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.20929 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
4.82845 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.48807 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.44998 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.21763 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
3.85712 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 |
3.80747 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.68389 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.48432 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.48432 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.36225 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.33788 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.32563 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, MAOB, XDH |
3.30285 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, F10, FDPS, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, XDH |
3.26098 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.17121 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PIM1, SLC1A1, SRC, TEK, XDH |
3.12383 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.96298 |
[MF] GO:0043168 |
anion binding
|
AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PIM1, SLC1A1, SRC, TEK, XDH |
2.89857 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
2.88391 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.82966 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.81073 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.65574 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, MAOB, XDH |
2.60636 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, MAOB, SRC, XDH |
2.59495 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.59495 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.59495 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5941 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5941 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.57647 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, HMGCR, MET, PTPN1 |
2.47067 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.3557 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.3557 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.3557 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.3066 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, FDPS, MMP1, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARA, PTPN1, RORC, SLC1A1, SMAD3, XDH |
2.24252 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, XDH |
2.24252 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.1893 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.1893 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.18821 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.15093 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PIM1, SRC, TEK, XDH |
2.11205 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NUAK1, PDE5A, PIM1, SRC, TEK, XDH |
2.11071 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.08421 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0605 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.04176 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, IGF1R, INSR |
2.00451 |